Gene therapy for sensorineural hearing loss

Ear and Hearing

Volumn 36, Issue 1, 2015, Pages 1-7

  Chien, Wade W ^a,b   Monzack, Elyssa L ^a   McDougald, Devin S ^a   Cunningham, Lisa L ^a  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gene therapy; Hair cell regeneration; Hearing loss; Ototoxicity

Indexed keywords

GENE THERAPY; GENETICS; HAIR CELL; HEARING LOSS, SENSORINEURAL; HUMAN; PROCEDURES; REGENERATION;

GENETIC THERAPY; HAIR CELLS, AUDITORY; HEARING LOSS, SENSORINEURAL; HUMANS; REGENERATION;

EID: 85027923320     PISSN: 01960202     EISSN: 15384667     Source Type: Journal    
DOI: 10.1097/AUD.0000000000000088     Document Type: Article

References (107)

1. Agrawal, Y., Platz, E. A., Niparko, J. K. (2008). Prevalence of hearing loss and differences by demographic characteristics among US adults: data from the National Health and Nutrition Examination Survey, 1999-2004. Arch Intern Med, 168, 1522-1530.
2. Akil, O., Seal, R. P., Burke, K., et al. (2012). Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy. Neuron, 75, 283-293.
3. Altschuler, R. A., Cho, Y., Ylikoski, J., et al. (1999). Rescue and regrowth of sensory nerves following deafferentation by neurotrophic factors. Ann N Y Acad Sci, 884, 305-311.
4. Anderson, A. C., Reddy, J., Nazareno, R., et al. (2004). IL-10 plays an important role in the homeostatic regulation of the autoreactive repertoire in naive mice. J Immunol, 173, 828-834.
5. Appollonio, I., Carabellese, C., Frattola, L., et al. (1996). Effects of sensory aids on the quality of life and mortality of elderly people: A multivariate analysis. Age Ageing, 25, 89-96.
6. Baek, M. J., Park, H. M., Johnson, J. M., et al. (2006). Increased frequencies of cochlin-specific T cells in patients with autoimmune sensorineural hearing loss. J Immunol, 177, 4203-4210.
7. Barnett, S., & Franks, P. (1999). Deafness and mortality: analyses of linked data from the National Health Interview Survey and National Death Index. Public Health Rep, 114, 330-336.
8. Bermingham, N. A., Hassan, B. A., Price, S. D., et al. (1999). Math1: An essential gene for the generation of inner ear hair cells. Science, 284, 1837-1841.
9. Bess, F. H., Lichtenstein, M. J., Logan, S. A., et al. (1989). Hearing impairment as a determinant of function in the elderly. J Am Geriatr Soc, 37, 123-128.
10. Brantly, M. L., Spencer, L. T., Humphries, M., et al. (2006). Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults. Hum Gene Ther, 17, 1177-1186.
11. Breyer, B., Jiang, W., Cheng, H., et al. (2001). Adenoviral vector-mediated gene transfer for human gene therapy. Curr Gene Ther, 1, 149-162.
12. Brignull, H. R., Raible, D. W., Stone, J. S. (2009). Feathers and fins: Nonmammalian models for hair cell regeneration. Brain Res, 1277, 12-23.
13. Cacciatore, F., Napoli, C., Abete, P., et al. (1999). Quality of life determinants and hearing function in an elderly population: Osservatorio Geriatrico Campano Study Group. Gerontology, 45, 323-328.
14. Cai, Q., Du, X., Zhou, B., et al. (2009). Induction of tolerance by oral administration of beta-tubulin in an animal model of autoimmune inner ear disease. ORL J Otorhinolaryngol Relat Spec, 71, 135-141.
15. Carabellese, C., Appollonio, I., Rozzini, R., et al. (1993). Sensory impairment and quality of life in a community elderly population. J Am Geriatr Soc, 41, 401-407.
16. Chen, P., Johnson, J. E., Zoghbi, H. Y., et al. (2002). The role of Math1 in inner ear development: Uncoupling the establishment of the sensory primordium from hair cell fate determination. Development, 129, 2495-2505.
17. Chia, E. M., Wang, J. J., Rochtchina, E., et al. (2007). Hearing impairment and health-related quality of life: The Blue Mountains Hearing Study. Ear Hear, 28, 187-195.
18. Cideciyan, A. V., Hauswirth, W. W., Aleman, T. S., et al. (2009). Vision 1 year after gene therapy for Leber's congenital amaurosis. N Engl J Med, 361, 725-727.
19. Corwin, J. T., & Cotanche, D. A. (1988). Regeneration of sensory hair cells after acoustic trauma. Science, 240, 1772-1774.
20. Cruickshanks, K. J., Wiley, T. L., Tweed, T. S., et al. (1998). Prevalence of hearing loss in older adults in Beaver Dam, Wisconsin. The Epidemiology of Hearing Loss Study. Am J Epidemiol, 148, 879-886.
21. Dalton, D. S., Cruickshanks, K. J., Klein, B. E., et al. (2003). The impact of hearing loss on quality of life in older adults. Gerontologist, 43, 661-668.
22. Dalton, D. S., Cruickshanks, K. J., Klein, R., et al. (1998). Association of NIDDM and hearing loss. Diabetes Care, 21, 1540-1544.
23. Dazert, S., Aletsee, C., Brors, D., et al. (2001). In vivo adenoviral transduction of the neonatal rat cochlea and middle ear. Hear Res, 151, 30-40.
24. Dazert, S., Battaglia, A., Ryan, A. F. (1997). Transfection of neonatal rat cochlear cells in vitro with an adenovirus vector. Int J Dev Neurosci, 15, 595-600.
25. Denoyelle, F., Weil, D., Maw, M. A., et al. (1997). Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum Mol Genet, 6, 2173-2177.
26. Derby, M. L., Sena-Esteves, M., Breakefield, X. O., et al. (1999). Gene transfer into the mammalian inner ear using HSV-1 and vaccinia virus vectors. Hear Res, 134, 1-8.
27. Di Pasquale, G., Rzadzinska, A., Schneider, M. E., et al. (2005). A novel bovine virus efficiently transduces inner ear neuroepithelial cells. Mol Ther, 11, 849-855.
28. Dubno, J. R., Dirks, D. D., Morgan, D. E. (1984). Effects of age and mild hearing loss on speech recognition in noise. J Acoust Soc Am, 76, 87-96.
29. Estivill, X., Fortina, P., Surrey, S., et al. (1998). Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet, 351, 394-398.
30. Friedmann, T., & Roblin, R. (1972). Gene therapy for human genetic disease? Science, 175, 949-955.
31. Fritzsch, B., Silos-Santiago, I., Bianchi, L. M., et al. (1997). The role of neurotrophic factors in regulating the development of inner ear innervation. Trends Neurosci, 20, 159-164.
32. Frucht, C. S., Uduman, M., Duke, J. L., et al. (2010). Gene expression analysis of forskolin treated basilar papillae identifies microRNA181a as a mediator of proliferation. PLoS One, 5, e11502.
33. Gates, G. A., Cooper, J. C., Jr., Kannel, W. B., et al. (1990). Hearing in the elderly: The Framingham cohort, 1983-1985 Part I Basic audiometric test results. Ear Hear, 11(4), 247-256.
34. Geschwind, M. D., Hartnick, C. J., Liu, W., et al. (1996). Defective HSV-1 vector expressing BDNF in auditory ganglia elicits neurite outgrowth: model for treatment of neuron loss following cochlear degeneration. Hum Gene Ther, 7, 173-182.
35. Gordon-Salant, S. (2005). Hearing loss and aging: new research findings and clinical implications. J Rehabil Res Dev, 42(4 Suppl 2), 9-24.
36. Green, G. E., Scott, D. A., McDonald, J. M., et al. (1999). Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA, 281, 2211-2216.
37. Halling, D. C., & Humes, L. E. (2000). Factors affecting the recognition of reverberant speech by elderly listeners. J Speech Lang Hear Res, 43, 414-431.
38. Han, J. J., Mhatre, A. N., Wareing, M., et al. (1999). Transgene expression in the guinea pig cochlea mediated by a lentivirus-derived gene transfer vector. Hum Gene Ther, 10, 1867-1873.
39. Holt, J. R., Johns, D. C., Wang, S., et al. (1999). Functional expression of exogenous proteins in mammalian sensory hair cells infected with adenoviral vectors. J Neurophysiol, 81, 1881-1888.
40. Humes, L. E., Watson, B. U., Christensen, L. A., et al. (1994). Factors associated with individual differences in clinical measures of speech recognition among the elderly. J Speech Hear Res, 37, 465-474.
41. Ishimoto, S., Kawamoto, K., Kanzaki, S., et al. (2002). Gene transfer into supporting cells of the organ of Corti. Hear Res, 173, 187-197.
42. Ives, D. G., Bonino, P., Traven, N. D., et al. (1995). Characteristics and comorbidities of rural older adults with hearing impairment. J Am Geriatr Soc, 43, 803-806.
43. Izumikawa, M., Minoda, R., Kawamoto, K., et al. (2005). Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med, 11, 271-276.
44. Jero, J., Mhatre, A. N., Tseng, C. J., et al. (2001). Cochlear gene delivery through an intact round window membrane in mouse. Hum Gene Ther, 12, 539-548.
45. Jiang, H., Couto, L. B., Patarroyo-White, S., et al. (2006). Effects of transient immunosuppression on adenoassociated, virus-mediated, liverdirected gene transfer in rhesus macaques and implications for human gene therapy. Blood, 108, 3321-3328.
46. Jiang, H., Gomez-Manzano, C., Lang, F. F., et al. (2009). Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas. Curr Gene Ther, 9, 422-427.
47. Kaplitt, M. G., Feigin, A., Tang, C., et al. (2007). Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: An open label, phase I trial. Lancet, 369, 2097-2105.
48. Kawamoto, K., Oh, S. H., Kanzaki, S., et al. (2001). The functional and structural outcome of inner ear gene transfer via the vestibular and cochlear fluids in mice. Mol Ther, 4, 575-585.
49. Kelley, M. W. (2006). Regulation of cell fate in the sensory epithelia of the inner ear. Nat Rev Neurosci, 7, 837-849.
50. Kelley, M. W., Driver, E. C., Puligilla, C. (2009). Regulation of cell fate and patterning in the developing mammalian cochlea. Curr Opin Otolaryngol Head Neck Surg, 17, 381-387.
51. Kelsell, D. P., Dunlop, J., Stevens, H. P., et al. (1997). Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature, 387, 80-83.
52. Kilpatrick, L. A., Li, Q., Yang, J., et al. (2011). Adeno-associated virusmediated gene delivery into the scala media of the normal and deafened adult mouse ear. Gene Ther, 18, 569-578.
53. Lalwani, A., Walsh, B., Reilly, P., et al. (1998). Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virus. Gene Ther, 5, 277-281.
54. Lalwani, A. K., Walsh, B. J., Reilly, P. G., et al. (1996). Development of in vivo gene therapy for hearing disorders: Introduction of adeno-associated virus into the cochlea of the guinea pig. Gene Ther, 3, 588-592.
55. Leake, P. A., Stakhovskaya, O., Hetherington, A., et al. (2013). Effects of brain-derived neurotrophic factor (BDNF) and electrical stimulation on survival and function of cochlear spiral ganglion neurons in deafened, developing cats. J Assoc Res Otolaryngol, 14, 187-211.
56. Lentz, J. J., Jodelka, F. M., Hinrich, A. J., et al. (2013). Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness. Nat Med, 19, 345-350.
57. Lenz, D. R., & Avraham, K. B. (2011). Hereditary hearing loss: From human mutation to mechanism. Hear Res, 281, 3-10.
58. Leventis, R., & Silvius, J. R. (1990). Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles. Biochim Biophys Acta, 1023, 124-132.
59. LeWitt, P. A., Rezai, A. R., Leehey, M. A., et al. (2011). AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol, 10, 309-319.
60. Li, H., Kloosterman, W., Fekete, D. M. (2010). MicroRNA-183 family members regulate sensorineural fates in the inner ear. J Neurosci, 30, 3254-3263.
61. Liberman, M. C., & Kiang, N. Y. (1984). Single-neuron labeling and chronic cochlear pathology. IV. Stereocilia damage and alterations in rate-and phase-level functions. Hear Res, 16, 75-90.
62. Luebke, A. E., Foster, P. K., Muller, C. D., et al. (2001). Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus-and adeno-associated virus-directed gene transfer. Hum Gene Ther, 12, 773-781.
63. Luebke, A. E., Steiger, J. D., Hodges, B. L., et al. (2001). A modified adenovirus can transfect cochlear hair cells in vivo without compromising cochlear function. Gene Ther, 8, 789-794.
64. Maeda, Y., Fukushima, K., Nishizaki, K., et al. (2005). In vitro and in vivo suppression of GJB2 expression by RNA interference. Hum Mol Genet, 14, 1641-1650.
65. Maguire, A. M., High, K. A., Auricchio, A., et al. (2009). Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: A phase 1 dose-escalation trial. Lancet, 374, 1597-1605.
66. Maguire, A. M., Simonelli, F., Pierce, E. A., et al. (2008). Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med, 358, 2240-2248.
67. Manjunath, N., Yi, G., Dang, Y., et al. (2013). Newer gene editing technologies toward HIV gene therapy. Viruses, 5, 2748-2766.
68. Manno, C. S., Pierce, G. F., Arruda, V. R., et al. (2006). Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med, 12, 342-347.
69. Maynard, C. L., & Weaver, C. T. (2008). Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation. Immunol Rev, 226, 219-233.
70. McCabe, B. F. (1979). Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol, 88(5 Pt 1), 585-589.
71. Mendell, J. R., Campbell, K., Rodino-Klapac, L., et al. (2010). Dystrophin immunity in Duchenne's muscular dystrophy. N Engl J Med, 363, 1429-1437.
72. Mingozzi, F., Hasbrouck, N. C., Basner-Tschakarjan, E., et al. (2007). Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver. Blood, 110, 2334-2341.
73. Mingozzi, F., & High, K. A. (2011). Therapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges. Nat Rev Genet, 12, 341-355.
74. Morton, N. E. (1991). Genetic epidemiology of hearing impairment. Ann N Y Acad Sci, 630, 16-31.
75. Moss, R. B., Milla, C., Colombo, J., et al. (2007). Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: A randomized placebo-controlled phase 2B trial. Hum Gene Ther, 18, 726-732.
76. Mulrow, C. D., Aguilar, C., Endicott, J. E., et al. (1990). Quality-of-life changes and hearing impairment. A randomized trial. Ann Intern Med, 113, 188-194.
77. Okada, H., Iizuka, T., Mochizuki, H., et al. (2012). Gene transfer targeting mouse vestibule using adenovirus and adeno-associated virus vectors. Otol Neurotol, 33, 655-659.
78. Oshima, K., Grimm, C. M., Corrales, C. E., et al. (2007). Differential distribution of stem cells in the auditory and vestibular organs of the inner ear. J Assoc Res Otolaryngol, 8, 18-31.
79. Praetorius, M., Baker, K., Weich, C. M., et al. (2003). Hearing preservation after inner ear gene therapy: The effect of vector and surgical approach. ORL J Otorhinolaryngol Relat Spec, 65, 211-214.
80. Rabinowitz, J. E., & Samulski, R. J. (2000). Building a better vector: the manipulation of AAV virions. Virology, 278, 301-308.
81. Raphael, Y., Frisancho, J. C., Roessler, B. J. (1996). Adenoviral-mediated gene transfer into guinea pig cochlear cells in vivo. Neurosci Lett, 207, 137-141.
82. Rudnicki, A., & Avraham, K. B. (2012). microRNAs: the art of silencing in the ear. EMBO Mol Med, 4, 849-859.
83. Ruel, J., Emery, S., Nouvian, R., et al. (2008). Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice. Am J Hum Genet, 83, 278-292.
84. Ryals, B. M., & Rubel, E. W. (1988). Hair cell regeneration after acoustic trauma in adult Coturnix quail. Science, 240, 1774-1776.
85. Schlecker, C., Praetorius, M., Brough, D. E., et al. (2011). Selective atonal gene delivery improves balance function in a mouse model of vestibular disease. Gene Ther, 18, 884-890.
86. Seal, R. P., Akil, O., Yi, E., et al. (2008). Sensorineural deafness and seizures in mice lacking vesicular glutamate transporter 3. Neuron, 57, 263-275.
87. Simonelli, F., Maguire, A. M., Testa, F., et al. (2010). Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Mol Ther, 18, 643-650.
88. Sinkkonen, S. T., Chai, R., Jan, T. A., et al. (2011). Intrinsic regenerative potential of murine cochlear supporting cells. Sci Rep, 1, 26.
89. Staecker, H., Li, D., O'Malley, B. W. Jr, et al. (2001). Gene expression in the mammalian cochlea: A study of multiple vector systems. Acta Otolaryngol, 121, 157-163.
90. Staecker, H., Praetorius, M., Baker, K., et al. (2007). Vestibular hair cell regeneration and restoration of balance function induced by math1 gene transfer. Otol Neurotol, 28, 223-231.
91. Strawbridge, W. J., Wallhagen, M. I., Shema, S. J., et al. (2000). Negative consequences of hearing impairment in old age: A longitudinal analysis. Gerontologist, 40, 320-326.
92. Thaci, B., Ulasov, I. V., Wainwright, D. A., et al. (2011). The challenge for gene therapy: Innate immune response to adenoviruses. Oncotarget, 2, 113-121.
93. Thorne, M., Salt, A. N., DeMott, J. E., et al. (1999). Cochlear fluid space dimensions for six species derived from reconstructions of three-dimensional magnetic resonance images. Laryngoscope, 109, 1661-1668.
94. Tsuruoka, H., Masuda, S., Ukai, K., et al. (2001). Hearing impairment and quality of life for the elderly in nursing homes. Auris Nasus Larynx, 28, 45-54.
95. Uhlmann, R. F., Larson, E. B., Rees, T. S., et al. (1989). Relationship of hearing impairment to dementia and cognitive dysfunction in older adults. JAMA, 261, 1916-1919.
96. Wallhagen, M. I., Strawbridge, W. J., Shema, S. J., et al. (2001). Comparative impact of hearing and vision impairment on subsequent functioning. J Am Geriatr Soc, 49, 1086-1092.
97. Walters, R. W., Yi, S. M., Keshavjee, S., et al. (2001). Binding of adenoassociated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J Biol Chem, 276, 20610-20616.
98. Wareing, M., Mhatre, A. N., Pettis, R., et al. (1999). Cationic liposome mediated transgene expression in the guinea pig cochlea. Hear Res, 128, 61-69.
99. White, P. M., Doetzlhofer, A., Lee, Y. S., et al. (2006). Mammalian cochlear supporting cells can divide and trans-differentiate into hair cells. Nature, 441, 984-987.
100. Wiley, T. L., Cruickshanks, K. J., Nondahl, D. M., et al. (1998). Aging and word recognition in competing message. J Am Acad Audiol, 9, 191-198.
101. Wise, A. K., Tu, T., Atkinson, P. J., et al. (2011). The effect of deafness duration on neurotrophin gene therapy for spiral ganglion neuron protection. Hear Res, 278, 69-76.
102. Xia, L., Yin, S., Wang, J. (2012). Inner ear gene transfection in neonatal mice using adeno-associated viral vector: A comparison of two approaches. PLoS One, 7, e43218.
103. Yamasoba, T., Yagi, M., Roessler, B. J., et al. (1999). Inner ear transgene expression after adenoviral vector inoculation in the endolymphatic sac. Hum Gene Ther, 10, 769-774.
104. Yang, S. M., Chen, W., Guo, W. W., et al. (2012). Regeneration of stereocilia of hair cells by forced Atoh1 expression in the adult mammalian cochlea. PLoS One, 7, e46355.
105. Yu, Q., Wang, Y., Chang, Q., et al. (2014). Virally expressed connexin26 restores gap junction function in the cochlea of conditional Gjb2 knockout mice. Gene Ther, 21, 71-80.
106. Zhou, B., Kermany, M. H., Cai, Q., et al. (2012). Experimental autoimmune hearing loss is exacerbated in IL-10-deficient mice and reversed by IL-10 gene transfer. Gene Ther, 19, 228-235.
107. Zhou, B., Kermany, M. H., Glickstein, J., et al. (2011). Murine autoimmune hearing loss mediated by CD4+ T cells specific for beta-tubulin. Clin Immunol, 138(2), 222-230.